Purchase Order HHSP284201600071A
- Not listed
- This is a delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Valneva USA, Inc., which does business as Intercell USA Inc. The contract is for the supply of the IXIARO vaccine, a Japanese encephalitis vaccine, with a firm fixed price of $130,235.00 and a completion date of June 15, 2019. The contract is not set aside and is issued under Valneva USA's General Services Administration Schedule 61-IB contract for...
- This is a firm fixed-price delivery order awarded by the Bureau of Medical Services, a civilian agency, to Valneva USA, Inc. (doing business as Intercell USA Inc.), a foreign-owned for-profit organization. The order is for the supply of the IXIARO Japanese encephalitis vaccine, with an ultimate completion date of September 30, 2024 and a ceiling value of $56,646.00. The contract was issued under the General Services Administration (GSA) Pharmaceutical and Drugs Federal Supply Schedule...
- This federal contract award, valued at $10,638,400.00, was issued by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, for the supply of the Japanese encephalitis vaccine IXIARO. The contract is a firm fixed price delivery order with a period of performance through September 30, 2024. Valneva USA, a subsidiary of the France-based Valneva SE, is the prime contractor and holds several other significant...
- This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Valneva USA, Inc. (dba Intercell USA Inc.), a foreign-owned for-profit organization. The $18,760.75 order is for the supply of the Japanese encephalitis vaccine IXIARO, which is being delivered against Valneva USA's General Services Administration (GSA) Schedule 61-IB contract for Pharmaceuticals and Drugs. This order has an ultimate completion date of...
- The U.S. Department of State's Office of the Assistant Secretary for Administration awarded a $172,232 firm fixed-price purchase order to Valneva USA, Inc. (doing business as Intercell USA Inc.) on January 6, 2026, for Japanese encephalitis vaccine to protect State Department personnel and their families. The contract carries a total small business set-aside designation and is scheduled for completion by January 6, 2026, with performance taking place in Bethesda, Maryland. Valneva USA is a...
- This is a $16,016,000.00 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the supply of the Japanese encephalitis vaccine IXIARO. This delivery order is part of a larger $48,025,600 indefinite delivery contract awarded to Valneva USA in September 2023, which supports the Department of Defense's medical...
- This federal contract award, with ID SPE2DP16D0003|0004, was issued by the Defense Logistics Agency Troop Support Medical to the prime contractor Valneva USA, Inc. (doing business as Intercell USA Inc.), a foreign-owned, for-profit organization. The $2,626,750.00 firm fixed-price delivery order contract is for the supply of the Japanese encephalitis vaccine IXIARO, with a period of performance through March 2, 2017. Valneva USA, Inc. holds several significant federal contract vehicles with the...
- This federal contract award, SPE2DP16D0003|0001, was issued by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc., doing business as Intercell USA Inc. The contract is for the delivery of the Japanese encephalitis vaccine IXIARO, and has a ceiling value of $9,262,750.00. The contract was awarded on March 18, 2016, with a completion date of July 18, 2016, and is a Firm Fixed Price Delivery Order. The award was not set aside for any particular business classification....
- This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Valneva USA, Inc. - doing business as Intercell USA Inc. - to provide the IXIARO Japanese encephalitis virus vaccine. The $247,897.00 firm fixed price delivery order was placed against Valneva's GSA Schedule 61 contract for Pharmaceuticals and Drugs. The delivery order has a completion date of March 15, 2022 and was awarded on February 15, 2022. This order is part of Valneva's broader...
- This is a delivery order contract awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Valneva USA, Inc., a foreign-owned, for-profit organization, for the supply of the IXIARO Japanese encephalitis vaccine. The contract, valued at $83,722.50, is a firm fixed-price delivery order issued against the Pharmaceuticals and Drugs (FSS-61-IB) federal supply schedule contract and has no set-aside designation. Valneva USA, Inc. has been awarded multiple...
This is a federal contract award to Valneva USA, Inc., doing business as Intercell USA Inc., for the supply of the IXIARO Japanese encephalitis vaccine. The $86,608.50 fixed-price purchase order was awarded on February 25, 2016 by the Office of the Assistant Secretary for Administration, a civilian federal agency. The contract has a completion date of March 11, 2016 and was not set aside for any specific business type. Valneva USA is a foreign-owned, for-profit organization that specializes in the development, manufacturing, and delivery of vaccines targeting infectious diseases. The company has been awarded multiple federal contracts and indefinite delivery vehicles (IDVs) by agencies such as the Department of Defense, Department of Veterans Affairs, Department of Health and Human Services, and the Federal Bureau of Investigation, primarily for the supply of the IXIARO vaccine and other medical countermeasures to support military, public health, and medical readiness initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $86.6k | 2/25/16 |